Boston University Clinical and Translational Science Institute
Project Number5UL1TR001430-09
Contact PI/Project LeaderCENTER, DAVID M. Other PIs
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
The Boston University Clinical and Translational Science Institute (BU CTSI) is an innovative CTSA clinical and
translational research hub and catalyst for national CTSA network science. Boston University and partner,
Boston Medical Center Health System (affiliate with Boston HealthNet, Boston Accountable Care Organization,
VA Boston Health System, Edith Norse Rogers Veterans Hospital and the HealthCore/New England Research
Institutes, Inc.) to comprise the members of the BU CTSI. We serve the largest URG and At Risk patient
populations in New England. Our overarching theme is meant to emphasize our commitment to developing
translational research infrastructure that is appropriate and innovative to meet the standards of the
CTSA Network AND is uniquely designed to meet the needs and overcome the many barriers in
partnering in research with patients at risk for poor health and outcomes. In order to address the health
needs of these communities, the BU CTSI will support workforce development, collaboration across our
stakeholders and integration of translational science across the lifespan of our Special Populations the through
the development of a competent workforce, use of novel informatics, methods and processes that address
disparities of health care. The BU CTSI Goals are:
Aim 1. Discover, demonstrate, deploy and disseminate novel methods in training that will enhance our entire
translational science workforce and create opportunities for advancement.
Aim 2. Develop the most efficient, most representative clinical trials hub possible employing the integrated
resources of all our partners.
Aim 3. Effect meaningful multi-directional relationships among all our community stakeholders that strengthen
collaborative translational research across the lifespan of our special populations and enable novel approaches
to integrating research into health care.
Aim 4. In collaboration with other CTSA hubs, discover, develop and disseminate innovative tools to improve
research on treatments and diagnostics that address national health problems:
The BU CTSI’s vision is to be the strongest possible advocate for, and participant in, translational research that
serves the health needs of our diverse At Risk patient populations by working with our community to create
unique resources that can be integrated with and distributed to the national CTSA network.
Public Health Relevance Statement
Boston University, The Boston Medical Center Health System, Boston HealtNet, Boston
Accountable Care Organization, VA Boston Health System, Edith Norse Rogers Veterans
Hospital and the HealthCore/New England Research institutes, Inc comprise the members
of the Boston University Clinical and Translational Science Institute (BU CTSI) Hub,
supported by a Clinical and Translational Science Award (CTSA) from the National Center
for Advancing Translational Science of the NIH. The goals of the BU CTSI, funded since
2008, are: 1. to train a diverse workforce; 2. improve and expedite translational research
across the members of the BU CTSI; 3. engage our community in research partnership;
4. develop new methods and resources that improve the science and performance of
translational research.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Academic Medical CentersAddressAdvocateBasic ScienceBostonCaringClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesCreativenessDevelopmentDiagnosticDisadvantagedDisparity populationDiverse WorkforceEnvironmentEthnic OriginFundingGenderGoalsHealthHealth SciencesHealth systemHealthcareHospitalsImmigrantIndividualInformaticsInfrastructureInsuranceLanguageLearningLongevityMaintenanceMedicaidMedical centerMethodsNational Center for Advancing Translational SciencesNew EnglandOutcomeParticipantPatientsPerformancePersonsPhysiciansPolicy MakerPopulationPrincipal InvestigatorProcessProviderPublic PolicyRaceRecording of previous eventsResearchResearch InfrastructureResearch InstituteResourcesRiskScienceScientistSocioeconomic StatusSpecial PopulationSubstance Use DisorderTrainingTranslational ResearchUnderinsuredUnited States National Institutes of HealthUniversitiesUrban PopulationVeterans HospitalsVisionWorkforce Developmentaccountable care organizationcatalystdesigndisorder controldistrustempowermentethnic diversityhealth care disparityhealth disparityimprovedinner cityinnovationlow socioeconomic statusmembermultidisciplinarynovelnovel strategiespatient populationpoor health outcomeprogramsracial diversityresidencesafety nettool
National Center for Advancing Translational Sciences
CFDA Code
350
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
13-August-2015
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2026
Project Funding Information for 2024
Total Funding
$6,633,234
Direct Costs
$4,020,142
Indirect Costs
$2,613,092
Year
Funding IC
FY Total Cost by IC
2024
National Center for Advancing Translational Sciences
$6,633,234
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5UL1TR001430-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5UL1TR001430-09
Patents
No Patents information available for 5UL1TR001430-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5UL1TR001430-09
Clinical Studies
No Clinical Studies information available for 5UL1TR001430-09
News and More
Related News Releases
No news release information available for 5UL1TR001430-09
History
No Historical information available for 5UL1TR001430-09
Similar Projects
No Similar Projects information available for 5UL1TR001430-09